Indications and uses
helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially ...
store at controlled room temperature: 15°C–25°C (59°F–77°F) protect this product from excessive heat and direct sun
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Titanium Dioxide 6.2% | Sunscreen |
| Zinc Oxide 15.6% | Sunscreen |
For external use only
Do not use on damaged or broken skin
Stop use and ask a doctor if rash occurs
When using this product keep out of eyes. Rinse with water to remove.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
aqua/water/eau, caprylic/capric triglyceride, dicaprylyl carbonate, pentylene glycol, steareth-2, glycerin, silica, polyhydroxystearic acid, steareth-21, cetearyl alcohol, propanediol, alumina, stearic acid, sodium stearoyl glutamate, caprylyl glycol, triethoxycaprylylsilane, cetearyl glucoslde, xanthan gum, dipotassium glycyrrhizate,trisodium ethylenediamine disuccinate, caprylhydroxamic acid, tropaeolum majus flower/leaf/stem extract.
1.800.636.7546 Monday–Friday 9 a.m.–4 p.m. PST
Distributed by Obagi Cosmeceuticals LLC,
Long Beach, CA 90806.
| Class | Version | Type | Effective |
|---|---|---|---|
| HYDROQUINONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 85490a6b-2306-6bf2-c51b-eb63537dc2da | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62032-100-36 | Obagi Nu-Derm System Normal-Oily Skin Transformation | 57 g in 1 BOTTLE, PLASTIC | CREAM | 57 g | 40 mg in 1g | 1 |
| 62032-101-36 | Obagi Nu-Derm System Normal-Oily Skin Transformation | 57 g in 1 BOTTLE, PLASTIC | CREAM | 57 g | 40 mg in 1g | 1 |
| 62032-811-09 | Obagi Nu-Derm System Normal-Oily Skin Transformation | 85 g in 1 TUBE | LOTION | 85 g | 6.2 g in 100g | 1 |
| 62032-811-09 | Obagi Nu-Derm System Normal-Oily Skin Transformation | 1 in 1 CARTON | LOTION | 6.2 g in 100g | 1 | |
| 62032-919-01 | Obagi Nu-Derm System Normal-Oily Skin Transformation | 1 in 1 BAG | KIT | 1 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62032-919 | 62032-919-01 |
| 62032-101 | 62032-101-36 |
| 62032-100 | 62032-100-36 |
| 62032-811 | 62032-811-09 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.